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CC BY-NC-ND license (http://creativeBackground: Transient tachypnea of the newborn (TTN) is a benign disorder with a variable clin-
ical course that often leads to hospitalization. The aim of this study was to assess and validate
the relationship between the serum cystatin C level and symptom duration in infants with TTN.
Methods: Forty newborns presenting with TTN and who had undergone serum cystatin C (Cys C)
tests on the first day of admission to the Kyung Hee University Hospital (Seoul, Korea) from 2009
to 2013 were included. The serum Cys C level, creatinine (Cr) level, estimated glomerular filtra-
tion rate (eGFR), and tachypnea duration were correlated retrospectively.
Results: The median gestation period was 37.8  3.8 weeks and the mean birth weight was
3.2  0.4 kg. Tachypnea duration was 3.3  2.0 days. Serum Cys C and Cr levels were
1.7  0.2 mg/L and 0.8  1.2 mg/dL, respectively. Tachypnea duration was significantly posi-
tively correlated with the serum levels of Cys C and significantly negatively correlated with
Cys C-based eGFR (pZ 0.016), but was not significantly correlated with the serum Cr level or
Cr-based eGFR. When tachypnea duration was compared between infants with Cys C level
<1.6 mg/L (nZ 15; Group A) and infants with Cys C level  1.6 mg/L (nZ 25; Group B), the
symptom duration was significantly shorter in Group A infants (pZ 0.011).
Conclusion: Tachypnea duration was shorter with higher Cys C-based eGFR in infants with TTN.
Copyright ª 2015, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).of Pediatrics, Kyung Hee University Hospital, 23 Kyungheedae-ro, Dongdaemun-gu, Seoul, zip code:
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196 B.B. Kim et al1. IntroductionTransient tachypnea of the newborn (TTN), a clinical syn-
drome first described by Avery et al1 in 1966, is accompa-
nied by respiratory distress. Its pathogenesis is unclear,
although it has been suggested that the development of
TTN may be associated with a delay in the reabsorption of
pulmonary alveolar fluid that prevents lung collapse during
the fetal period.1,2 Most cases of TTN consist of benign self-
limiting pulmonary disease, except for occasional severe
cases that require laboratory tests, chest radiography, and
admission into the neonatal intensive care unit (NICU) for
intensive respiratory treatment. The incidence of TTN is
w1e2% in all neonates,3 and the average symptom duration
is 2e5 days.4
Despite the relatively short hospital stay and benign
course, TTN is associated with social and financial burdens
because the affected infants are usually admitted to
NICUs.5 Therefore, several studies pertaining to TTN
symptom duration have been published. These studies have
focused on fluid redistribution because some clinicians have
used loop diuretics to treat patients with TTN. A recent
study revealed no apparent advantage in using furose-
mide,6 although another study demonstrated a significant
improvement in fluid-restricted TTN infants, which impli-
cates an association between fluid balance and TTN
symptoms.7
Because of its active effects on body fluid balance, the
renal function of infants with TTN was analyzed in the
current study to test the hypothesis that infants with a
shorter symptom duration would have better renal func-
tion. Serum cystatin C (Cys C) and creatinine (Cr) were
chosen for calculating the estimated glomerular filtration
rate (eGFR) because they are representative markers of
renal function.8 The aim of the current study was to eval-
uate the relationship between the eGFR, using serum Cys C,
and symptom duration in infants with TTN.2. Patients and methods2.1. Participants
This retrospective study was conducted at a single tertiary
care centerdKyung Hee University Hospital (Seoul,
Korea)dand was based on medical chart reviews. Before
the data were reviewed and analyzed, the Institutional
Review Board of the Kyung Hee University Hospital
approved the present study. Patients admitted to the NICU
of the Kyung Hee University Hospital from January 2009 to
July 2013 were screened with the following inclusion
criteria: gestational age 37 weeks; birth weight 2500 g;
a diagnosis of TTN without hyaline membrane disease,
pneumonia, or pneumothorax, as confirmed through chest
radiograph; and serum Cys C and Cr levels that were
measured on the 1st day of admission. Infants were
excluded that had renal failure (i.e., sustained plasma
creatinine level  1.5 mg/dL)9 or oliguria (i.e., urine
flow < 1 mL/kg/h).10 The Cys C level at the time of
admission was not assessed because of renal impairment
but as part of a routine serum chemistry battery.2.2. Data collection
Individual medical records were transcribed into the case
report forms and included sex, gestational age, and birth
weight. Data pertaining to Apgar scores at 1 minute and 5
minutes, type of delivery, urine output, serum Cys C level
on the 1st day of admission, and serum Cr were also
collected. Mean urine output values measured every 1e3
hours during the admission period were used as a repre-
sentative value of urine output. Serum levels of Cys C and
Cr were measured by an automated chemical analyzer
(Toshiba, Nasushiobara, Japan) using HiSens Cys-C LTIA (HBi
Co., Ltd., Anyang, Korea) and serum Cr (Kanto Chemical
Co., Tokyo, Japan), respectively. Serum Cr-based eGFR (Cr-
eGFR) and serum Cys C-based eGFR (Cys-eGFR) were
calculated using the following equations: (1) Cr-eGFR (in
term neonates) Z 0.45  length (cm)/serum Cr (mg/dL)
and (2) Cys C-eGFR Z 137/Cys C  20.4 (Bokencamp A).11
Based on the Cys C values, a cutoff of 1.6 mg/L (corre-
sponding to Cys C-eGFR 65 mL/min/1.73 m2) was used to
classify patients into two subgroups: (1) the low Cys C group
(Group A; n Z 15, Cys C < 1.6 mg/L, and Cys C-
eGFR > 65 mL/min/1.73 m2) and (2) the high Cys C group
(Group B; n Z 25, Cys C  1.6 mg/L, and Cys C-
eGFR  65 mL/min/1.73 m2).
2.3. Definitions
The time after admission to the resolution of tachypnea
was recorded. The measured respiratory rates (RRs) were
also reviewed from medical charts. Tachypnea was defined
as a breath rate of more than 60 breaths/min. The RR was
represented by the mean value of the RRs measured every
1e3 hours during the admission period of the patient. We
assessed the average values of every 8-hour period. Reso-
lution of tachypnea was defined as the day when the 8-hour
period average RR was below 60 breaths/min in two or
more consecutive periods.
2.4. Statistical analysis
The relationships between TTN symptom duration, serum
Cys C level, serum Cr level, and eGFRs measured on hos-
pital Day 1 were analyzed. The type of delivery, Apgar
scores at 1 minute and 5 minutes, and average gestational
period were also analyzed. All statistical analyses were
conducted using SPSS version 20.0 software (SPSS Inc.,
Chicago, IL, USA). The data are expressed as the mean 
the standard deviation. The ManneWhitney U test was used
to evaluate the differences between the low and high Cys C
subgroups. Pearson’s correlations and multivariate regres-
sion analyses were performed to examine the relationships
between symptom duration, urine output, Cr, cystatin C,
Cr-eGFR, and Cys C-eGFR. Statistical significance was set at
p < 0.05.
3. Results
From January 2009 to July 2013, a total of 65 TTN patients
older than 37 gestational weeks with a birth weight >2500 g
CysC-eGFR in TTN 197were admitted to the NICU of Kyung Hee University Hospi-
tal. Forty patients who met all inclusion criteria were
included as participants.
3.1. Baseline characteristics
The patient characteristics are presented in Table 1 and
expressed as the median and range.
3.2. Correlations with symptom duration
Symptom duration, urine output, serum Cys C, serum Cr,
Cys C-eGFR, and Cr-eGFR were correlated. No significant
correlations existed between TTN symptom duration and
the following: urine output, serum Cr, and Cr-eGFR
(p Z 0.336, p Z 0.653, and p Z 0.889, respectively).
However, serum Cys C and TTN symptom duration were
positively correlated (R Z 0.378, p Z 0.016), while Cys C-
eGFR was negatively correlated (R Z 0.778, p Z 0.016;
Table 2). Simple linear regression analysis showed a sig-
nificant association between Cys C and symptom duration
(R2 Z 0.157, p Z 0.015; Figure 1). Multivariate regression
analysis conducted to adjust for gestational age, birth
weight, sex, Apgar scores, delivery type, and urine output
demonstrated that the aforementioned results remained
statistically significant (R2 Z 0.141, p Z 0.02).
3.3. Correlations with urine output
Urine output was correlated with serum Cr, Cr-eGFR, serum
Cys C, and Cys C-eGFR. Urine output was not significantly
correlated with serum Cr or Cr-eGFR (p Z 0.677 and
p Z 0.359, respectively). However, serum Cys C and urine
output showed a significantly negative correlation,
(R Z 0.398, p Z 0.011). By contrast, Cys C-eGFR showed
a significantly positive correlation with urine output,
(R Z 0.363, p Z 0.021; Table 2).Table 1 The characteristics of newborn infants with transient
groups: Group A (i.e., Cys C < 1.6 mg/L) and Group B (i.e., Cys C
N Total Gro
40 15
Gestational age (wk) 38.1 (35.0e41.7) 38.
Birth weight (kg) 3223 (2420e4050) 331
Apgar score 8 (5e10)/9 (8e10)
C-section 25 (62.5)
Urine output (mL/kg/d) 66.5 (3.3e127.3) 81.
Serum cystatin C (mg/dL) 1.65 (1.1e2.2) 1.
eGFR-Cys (mL/min/1.73m2) 62.7 (41.9e104.1) 70.
Serum creatinine (mg/dL) 0.6 (0.3e8) 0.
eGFR-Cr (mL/min/1.73m2) 35.0 (2.1e79.5) 36.
Symptom duration (d) 1.70 (0.05e8.03) 1.4
Oxygen duration (d) 1.70 (0e7.49) 1.1
Data are presented as n (%) or median (range). Subgroup analysis betw
test.
C-section, caesarean section; Cr, serum creatinine; Cys, cystatin C, e
* Indicates a significant difference at p < 0.05.
y The Chi square test was performed.3.4. Differences between the high eGFR group and
low eGFR group
Symptom duration was shorter in Group A (median, 1.44
days) than in Group B (median, 2.28 days, p Z 0.011), and
urine output was greater in Group A (median, 81.8 mL/kg/
d) than in Group B (median, 55.6 mL/kg/d, pZ 0.01; Table
1). The cutoff value of 1.6 mg/dL Cys C had a sensitivity of
71.4% and a specificity of 47.4% based on a receiver oper-
ating characteristic (ROC) curve analysis.4. Discussion
The current study demonstrated that the serum Cys C level
and the Cys C-eGFR were significantly correlated with TTN
symptom duration. The TTN symptom duration was longer
in infants with higher serum Cys C levels and lower eGFR
levels. The pathogenesis of TTN is unclear, although a delay
in the clearance of the fetal lung fluid has been considered
as a potential cause.1 Fetal lung fluid has an important role
in fetal lung development through maintaining residual
volume to form the fetal lung capacity. Reabsorption of the
lung fluid begins 2e3 days before birth, and the epineph-
rine surge during labor further accelerates this proc-
ess.12e14 After the birth of infants with TTN, diuretic
treatment has occasionally been used under the assumption
that facilitating diuresis would further promote the trans-
portation of lung fluid into the pulmonary vascular bed.15
However, according to Kassab et al,16 furosemide treat-
ment in infants with TTN failed to alter the duration of
symptoms or the length of their hospital stay. By contrast,
Stroupstrup et al7 showed that fluid restriction reduced the
duration of respiratory support and associated hospitaliza-
tion costs in TTN neonates, which suggests an association
between fluid status and TTN symptoms.
The relationship between renal function and symptom
duration in TTN infants remains controversial. The resultstachypnea of the newborn. The infants are divided into two
 1.6 mg/L).
up A Group B p
25 N/A
7 (35.0e41.7) 38.0 (35.9e41.7) 0.288
0 (2600e3961) 3200 (2420e4050) 0.675
8 (5e9)/9 (8e10) 8 (6e10)/9 (8e10) 0.466/0.314
6 (40) 8 (32) 0.354y
8 (59.2e109.2) 55.6 (3.3e127.3) 0.010*
5 (1.1e1.5) 1.8 (1.6e2.2) 0.000*
9 (70.9e104.1) 55.7 (41.9e65.2) 0.000*
6 (0.3e8) 0.7 (0.4e0.9) 0.150
8 (2.1e79.5) 34.1 (25.0e58.5) 0.304
4 (0.05e3.41) 2.28 (0.43e8.03) 0.011*
0 (0e3.86) 2.34 (0.01e7.49) 0.148
een Group A and Group B was performed by the ManneWhitney U
GFR, estimated glomerular filtration rate.
Table 2 The correlations between symptom duration in infants with tachypnea of the newborn and renal parameters.
Symptom duration (d) Cystatin C
(mg/dL)
Creatinine
(mg/dL)
Urine output
(cc/kg/d)
eGFR-Cr
(mL/min/1.73m2)
eGFR-Cys
(mL/min/1.73m2)
R p R p R p R p R p R p
Symptom
duration
d d 0.378 0.016* 0.078 0.653 0.156 0.336 0.024 0.889 0.378 0.016*
Cystatin C 0.378 0.016* d d 0.199 0.243 0.398 0.011* 0.252 0.138 0.979 0.000*
Creatinine 0.078 0.653 0.199 0.243 d d 0.072 0.677 0.535 0.001* 0.220 0.196
Urine output 0.156 0.336 0.398 0.011* 0.072 0.677 d d 0.157 0.359 0.363 0.021*
eGFR-Cr 0.024 0.889 0.252 0.138 0.535 0.001 0.157 0.359 d d 0.275 0.104
eGFR-Cys 0.378 0.016* 0.979 0.000* 0.220 0.196 0.363 0.021* 0.275 0.104 d d
Cr, serum creatinine; Cys, cystatin C; eGFR, estimated glomerular filtration rate; R, Pearson’s correlation coefficient.
* Indicates a statistical significance at p < 0.05.
198 B.B. Kim et alof the current study demonstrated a significant association
between symptom duration and Cys C, but not with urine
output. This suggests that the degree of maturation such as
managing ions through channels, as opposed to simple urine
output, is a more important factor for consideration. A
commonly shared linkage between the lungs and kidneys in
neonates immediately after birth remains speculative.
Although we did not examine specific ion channel mecha-
nisms in the current study, we suggest that epithelial so-
dium channels (ENaCs) and sodium-potassium adenine
triphosphatase (Na/K-ATPase) may be key mechanisms in
this linkage, based on their important roles in fluid man-
agement in the lungs and in the kidneys. During the dy-
namic process of the fluid status change in the lungs in the
peripartum stage, sodium (Naþ) is the most important
actively transported ion.17 Epithelial sodium channelsFigure 1 Tachypnea duration, based on the serum cystatin C leve
Cys C level (pZ 0.016) is evident. The solid lines represent the regr
linear regression analysis is as follows: tachypnea duration (days)allows Naþ to move from the alveolar lumen through the
basolateral membrane, and Na/K-ATPase relocates Naþ to
the interstitium.12 Shortly after the labor process is
induced, the expression of ENaC and Na/K-ATPase in the
lung epithelium accelerates, which changes the lung
epithelium from a chloride-secreting membrane to a
sodium-absorbing membrane. These changes facilitate the
absorption of lung fluid into the pulmonary vascular bed
and into the interstitium.18e20
Infants presenting with TTN have ineffective ion channel
switching in the pulmonary epithelium,7 whereas other
mechanical factors also affect the onset of TTN.4 A similar
process has also been demonstrated in the kidneys where
Naþ transport has an important role in the antenatal
maturation of the kidneys. The highly maintained fractional
excretion of Naþ decreases dramatically at the beginning ofl. A positive correlation between symptom duration and serum
ession line and mean confidence interval. The formula used for
Z 2.835  serum Cystatin C (mg/dL)  2.512.
CysC-eGFR in TTN 199birth,21,22 and results in the removal of interstitial fluid.
The transition from a negative to a positive Naþ balance
subsequently occurs.23 Epithelial sodium channel in the
distal convoluted tubule, collecting tubule, and principal
cells of the collecting duct also have important roles in Naþ
reabsorption, and collectively regulate the extracellular
fluid volume in a precise manner. The finding that the a
subunit of Na/K-ATPase and the nephrons have parallel
maturation also supports such an association.24 Thus, ENaC
and Na/K-ATPase determine the fluid volume in the lungs
and in the kidneys. These similar mechanisms, which are
associated with fluid reabsorption, suggest a connection
between renal function and TTN.25
There are several risk factors that aggravate TTN
symptoms such as male sex, Cesarean section delivery, low
Apgar score, acidosis, and myocardial dysfunction.26,27
Lactate dehydrogenase and digoxin-like immunoreactive
substance have also been implicated in a few studies.28,29
However, practical biochemical markers that can be used
to predict the prognosis of TTN have yet to be discovered.
In the current study, serum GFR and Cys C were used as
biomarkers to estimate the glomerular filtration rate (GFR)
in infants with TTN. The Cys C level is especially useful in
neonates, and unlike serum Cr, it is unaffected by gesta-
tional age or maternal GFR.7,30,31 Although controversy
remains, the normal physiologic ranges of Cys C and Cys C-
eGFR in term neonates (i.e., gestational period > 37 weeks)
in the first 3 days after birth are 1.21  0.31 mg/L and
65.55  30.45 mL/min/1.73 m2, respectively.26 Based on
our eGFR equation, which differed from the equations used
in the aforementioned studies, the eGFR of 65 mL/min/
1.73 m2 in infants with TTN was associated with a Cys C
level of 1.6 mg/dL. The corresponding eGFR value for Cys C
1.6 mg/dL was 65.225 mL/min/1.73 m2 when using our
formula. In addition, 1.6 mg/dL of Cys C corresponded to
our observed median level of Cys C in all 40 patients
examined. Based on the cutoff Cys C level of 1.6 mg/dL,
infants with a higher Cys C and lower a Cys C-eGFR had a
longer tachypnea duration. The ROC curve using this cutoff
value demonstrated a sensitivity of 71.4% and a specificity
of 47.4%. These results suggest that this method may not be
an excellent test tool, but is more likely a useful indicator,
if further study is warranted.
To the best of our knowledge, this is the first attempt to
evaluate the relationships between Cys C, eGFR calculated
using Cys C, and TTN symptom duration. Serum Cys C and
Cys C-eGFR showed significant correlations with TTN
symptom duration, which suggests an association between
renal function and TTN symptom duration. In a different
study by Kara et al,10 the authors hypothesized that insuf-
ficient lung fluid elimination resulted from a lack of N-ter-
minal probrain natriuretic peptide (NT-proBNP) in infants
with TTN. However, no significant difference was found
between the NT-proBNP levels in infants with TTN and
members of a control group.10
The principal limitation of the current study was the
inability to exclude other factors such as sepsis or hyper-
thyroidism that can affect serum Cys C levels. In addition,
the small number of patients in our cohort limited the sta-
tistical power of the study. Because of the low R2 in our
study, careful deliberation and further studies will be
required.Data from the current study revealed that serum Cys C
and serum Cys C-eGFR showed positive and negative cor-
relations with TTN symptom duration, respectively. The
high GFR group showed a statistically shorter TTN symptom
duration as compared with the low GFR group. However, Cr-
eGFR and urine output did not correlate with TTN symptom
duration. Further studies regarding the utilization of Cys C
as a cost efficient and easily obtained predictive index for
TTN symptom duration are needed. Moreover, treatments
for TTN that take measurements of renal function into ac-
count will also require additional research.Conflicts of interest
The authors have no conflicts of interest relevant to this
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